Pediatric Histiocytosis Clinical Trials

A Study to Investigate the Safety and Efficacy of an Anti-IFNγ mAb in Children Affected by Primary Haemophagocytic Lymphohistiocytosis

The purpose of this study is to assess the safety, tolerability and efficacy of a new drug aimed at controlling disease activity in patients diagnosed with primary haemophagocytic lymphohistiocytos...

Diagnosis: Pediatric Histiocytosis

Phase: 2 / 3

Protocol Number: 14-018

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18 years).

Diagnosis: Pediatric Histiocytosis

Phase: 2 / 3

Protocol Number: 13-428

Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis

This research study is evaluating a drug called clofarabine as a possible treatment for Langerhans Cell Histiocytosis( LCH )

Diagnosis: Pediatric Histiocytosis

Phase: 2

Protocol Number: 15-005